home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9406d.zip
/
M9460745.TXT
< prev
next >
Wrap
Text File
|
1994-06-25
|
2KB
|
28 lines
Document 0745
DOCN M9460745
TI Estimating the value of preventing a human immunodeficiency virus
infection.
DT 9408
AU Guinan ME; Farnham PG; Holtgrave DR; Office of HIV/AIDS, Centers for
Disease Control and Prevention,; Atlanta, GA 30333.
SO Am J Prev Med. 1994 Jan-Feb;10(1):1-4. Unique Identifier : AIDSLINE
MED/94226823
AB We estimated the medical cost savings for a case of human
immunodeficiency virus (HIV) infection prevented. Using medical care
cost estimates, assumptions concerning knowledge of serostatus, time
spent in various stages of HIV disease, and a discount factor, we
estimated the present value of future cost savings for a case of HIV
prevented, which ranged from $56,000 to $80,000. Since this method
excludes both indirect costs and direct costs other than medical care,
these figures underestimate the true cost savings for a case of HIV
prevented. However, the method may prove useful in assigning a
systematic economic value to an HIV infection averted that can be used
in cost-benefit analyses of HIV prevention interventions.
DE *Cost Savings *Health Care Costs/STATISTICS & NUMER DATA Human HIV
Infections/*ECONOMICS/PREVENTION & CONTROL Time Factors JOURNAL
ARTICLE
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).